NPI 1629409552: Open Payments
NPI 1629409552. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$218 in 9 payments from 6 companies in 2025. Trend: 2023 $200 · 2024 $382 · 2025 $218
Food & beverage: $218
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $98 |
| Amgen Inc. | 2 | $38 |
| Hologic Sales and Service, LLC | 1 | $25 |
| Exeltis, USA Inc. | 1 | $22 |
| SHIELD THERAPEUTICS INC | 1 | $20 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Veozah, EVENITY, THINPREP 2000 PROCESSOR, SLYND, ACCRUFER, The Cologuard Plus Collection Kit.
